Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 222
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
PT277 – Ryan Zurrer – Venture Capital, Reciprocity, and the Regenerative...
MINDCURE Appoints Dr. Doron Sagman as Chief Medical Officer
MAPS and Wesana Health Resume Negotiations
Field Trip Launches Site Management Organization (SMO) Services, Hires Stéphan Côté...
MindMed Appoints Robert Barrow as Chief Executive Officer and Director
atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...
Lobe Sciences Announces That Its Shares Will Trade on the OTCQB(R)...
PharmaDrug Announces Addition of Dr. Cindy Hutnik, President of the Canadian...
HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S....
atai Life Sciences Has Been Selected for Addition to the NASDAQ...
Load more